Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Zhi-chun Ding"'
Autor:
Gang Zhou, David H Munn, Zhi-Chun Ding, Marco L Davila, Hongyan Xu, Nada S Aboelella, Caitlin Brandle, Ogacheko Okoko, Md Yeashin Gazi, Gregory Gorman, Roni Bollag, Locke J Bryan, Gary A Piazza
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Adoptive cell therapy (ACT) using genetically modified T cells has evolved into a promising treatment option for patients with cancer. However, even for the best-studied and clinically validated CD19-targeted chimeric antigen receptor (CAR
Externí odkaz:
https://doaj.org/article/a814f619a9934bacafbe74860b95a4f2
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Cyclophosphamide (CTX) is a major component of the chemotherapy conditioning regimens used in the clinic to prepare cancer patients for hematopoietic stem cell transplantation or adoptive T cell therapy. Previous studies have shown that CTX given at
Externí odkaz:
https://doaj.org/article/3421a30b17504bd98866e5f8b47e1590
Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
Autor:
Zhi-Chun Ding, Gang Zhou
Publikováno v:
Clinical and Developmental Immunology, Vol 2012 (2012)
Standard cytotoxic chemotherapy can initially achieve high response rates, but relapses often occur in patients and represent a severe clinical problem. As increasing numbers of chemotherapeutic agents are found to have immunostimulatory effects, the
Externí odkaz:
https://doaj.org/article/7ddfab3fe3d64e9f85a81e6223e78fbe
Autor:
Han-Fei Ding, Yunhong Zha, Zheng Dong, Chunhong Yan, Oliver Fiehn, Bei Gao, Jeong-Hyeon Choi, Eun Jeong Park, Zhi-Chun Ding, Puttur D. Prasad, Muthusamy Thangaraju, Ahmet Alptekin, Yajie Yu, Jane Ding, Bingwei Ye, Yingfeng Xia
Supplementary Figures: SF1, MYCN amplification vs SGOC gene expression; SF2, MYCN activates SGOC gene expression; SF3, ATF4 activates SGOC gene expression; SF4, MYCN and ATF4 form a positive feedback loop; SF5, MYCN sensitizes neuroblastoma cells to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4eed00d7c89db6dda33a973da94ab0
https://doi.org/10.1158/0008-5472.22422483
https://doi.org/10.1158/0008-5472.22422483
Autor:
Han-Fei Ding, Yunhong Zha, Zheng Dong, Chunhong Yan, Oliver Fiehn, Bei Gao, Jeong-Hyeon Choi, Eun Jeong Park, Zhi-Chun Ding, Puttur D. Prasad, Muthusamy Thangaraju, Ahmet Alptekin, Yajie Yu, Jane Ding, Bingwei Ye, Yingfeng Xia
List of genes regulated by the PHGDH inhibitor NCT-503
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e78d219779645b411c5d315f84079d4
https://doi.org/10.1158/0008-5472.22422480
https://doi.org/10.1158/0008-5472.22422480
Autor:
Han-Fei Ding, Yunhong Zha, Zheng Dong, Chunhong Yan, Oliver Fiehn, Bei Gao, Jeong-Hyeon Choi, Eun Jeong Park, Zhi-Chun Ding, Puttur D. Prasad, Muthusamy Thangaraju, Ahmet Alptekin, Yajie Yu, Jane Ding, Bingwei Ye, Yingfeng Xia
MYCN amplification drives the development of neuronal cancers in children and adults. Given the challenge in therapeutically targeting MYCN directly, we searched for MYCN-activated metabolic pathways as potential drug targets. Here we report that neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8122c6704fb536426d3c3ca32e8ae49f
https://doi.org/10.1158/0008-5472.c.6511236.v1
https://doi.org/10.1158/0008-5472.c.6511236.v1
Autor:
Gang Zhou, David H. Munn, Andrew L. Mellor, Bruce R. Blazar, Matthias Mack, Antoni Krasinski, Matthew Walters, Kebin Liu, Phillip Chandler, Lei Huang, Henrique Lemos, Miao Yu, Xiaoyun Lu, Zhi-Chun Ding
PDF file - 30KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11771d5d44699c7f01aaa75a58aeacf2
https://doi.org/10.1158/0008-5472.22404189.v1
https://doi.org/10.1158/0008-5472.22404189.v1
Autor:
Gang Zhou, David H. Munn, Andrew L. Mellor, Bruce R. Blazar, Matthias Mack, Antoni Krasinski, Matthew Walters, Kebin Liu, Phillip Chandler, Lei Huang, Henrique Lemos, Miao Yu, Xiaoyun Lu, Zhi-Chun Ding
PDF file - 133KB, Immunofluorescence staining (IF) of CD11b+ myeloid cells on spleen and tumor samples (S1). CTX+CD4 AT therapy induces an inflammatory immune milieu (S2). Chemoimmunotherapy leads to myeloid cell expansion in mice with lung metastasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79cf54b24c8ac241c6f8217db78da49e
https://doi.org/10.1158/0008-5472.22404183.v1
https://doi.org/10.1158/0008-5472.22404183.v1
Autor:
Gang Zhou, David H. Munn, Andrew L. Mellor, Bruce R. Blazar, Matthias Mack, Antoni Krasinski, Matthew Walters, Kebin Liu, Phillip Chandler, Lei Huang, Henrique Lemos, Miao Yu, Xiaoyun Lu, Zhi-Chun Ding
PDF file - 27KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8922380d8a35217ac097fd38b2d27fc
https://doi.org/10.1158/0008-5472.22404180.v1
https://doi.org/10.1158/0008-5472.22404180.v1
Autor:
Nada S Aboelella, Caitlin Brandle, Ogacheko Okoko, Md Yeashin Gazi, Zhi-Chun Ding, Hongyan Xu, Gregory Gorman, Roni Bollag, Marco L Davila, Locke J Bryan, David H Munn, Gary A Piazza, Gang Zhou
Publikováno v:
Journal for immunotherapy of cancer. 10(7)
BackgroundAdoptive cell therapy (ACT) using genetically modified T cells has evolved into a promising treatment option for patients with cancer. However, even for the best-studied and clinically validated CD19-targeted chimeric antigen receptor (CAR)